SPSB1 may have MET its match during breast cancer recurrence

Cancer Discov. 2014 Jul;4(7):760-1. doi: 10.1158/2159-8290.CD-14-0505.

Abstract

Disease recurrence is the most common cause of death for patients with breast cancer, yet little is known about the molecular mechanisms underlying this process. Using inducible transgenic mouse model systems, Feng and colleagues identified SPSB1 as a determinant of breast cancer recurrence by virtue of its ability to protect tumor cells from apoptosis through c-MET activation.

Publication types

  • Comment

MeSH terms

  • Animals
  • Breast Neoplasms / genetics*
  • Female
  • Humans
  • Neoplasm Recurrence, Local / genetics*
  • Proto-Oncogene Proteins c-met / metabolism*
  • Suppressor of Cytokine Signaling Proteins / genetics*

Substances

  • Suppressor of Cytokine Signaling Proteins
  • Proto-Oncogene Proteins c-met